Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer

P. Vychytilova-Faltejskova, A. Svobodova Kovarikova, T. Grolich, V. Prochazka, K. Slaba, T. Machackova, J. Halamkova, M. Svoboda, Z. Kala, I. Kiss, O. Slaby,

. 2019 ; 20 (18) : . [pub] 20190910

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005920

Grantová podpora
16-31765A Ministerstvo Zdravotnictví Ceské Republiky
NV16-31765A MZ0 CEP - Centrální evidence projektů

MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression. Each step of their production and maturation has to be strictly regulated, as any disruption of control mechanisms may lead to cancer. Thus, we have measured the expression of 19 genes involved in miRNAs biogenesis pathway in tumor tissues of 239 colorectal cancer (CRC) patients, 17 CRC patients with liver metastases and 239 adjacent tissues using real-time PCR. Subsequently, the expression of analyzed genes was correlated with the clinical-pathological features as well as with the survival of patients. In total, significant over-expression of all analyzed genes was observed in tumor tissues as well as in liver metastases except for LIN28A/B. Furthermore, it was shown that the deregulated levels of some of the analyzed genes significantly correlate with tumor stage, grade, location, size and lymph node positivity. Finally, high levels of DROSHA and TARBP2 were associated with shorter disease-free survival, while the over-expression of XPO5, TNRC6A and DDX17 was detected in tissues of patients with shorter overall survival and poor prognosis. Our data indicate that changed levels of miRNA biogenesis genes may contribute to origin as well as progression of CRC; thus, these molecules could serve as potential therapeutic targets.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005920
003      
CZ-PrNML
005      
20200518132207.0
007      
ta
008      
200511s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms20184460 $2 doi
035    __
$a (PubMed)31510013
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Vychytilova-Faltejskova, Petra $u Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic. vychytilova.petra@seznam.cz.
245    10
$a MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer / $c P. Vychytilova-Faltejskova, A. Svobodova Kovarikova, T. Grolich, V. Prochazka, K. Slaba, T. Machackova, J. Halamkova, M. Svoboda, Z. Kala, I. Kiss, O. Slaby,
520    9_
$a MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression. Each step of their production and maturation has to be strictly regulated, as any disruption of control mechanisms may lead to cancer. Thus, we have measured the expression of 19 genes involved in miRNAs biogenesis pathway in tumor tissues of 239 colorectal cancer (CRC) patients, 17 CRC patients with liver metastases and 239 adjacent tissues using real-time PCR. Subsequently, the expression of analyzed genes was correlated with the clinical-pathological features as well as with the survival of patients. In total, significant over-expression of all analyzed genes was observed in tumor tissues as well as in liver metastases except for LIN28A/B. Furthermore, it was shown that the deregulated levels of some of the analyzed genes significantly correlate with tumor stage, grade, location, size and lymph node positivity. Finally, high levels of DROSHA and TARBP2 were associated with shorter disease-free survival, while the over-expression of XPO5, TNRC6A and DDX17 was detected in tissues of patients with shorter overall survival and poor prognosis. Our data indicate that changed levels of miRNA biogenesis genes may contribute to origin as well as progression of CRC; thus, these molecules could serve as potential therapeutic targets.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biosyntetické dráhy $x genetika $7 D053898
650    _2
$a kolorektální nádory $x genetika $x patologie $7 D015179
650    _2
$a ženské pohlaví $7 D005260
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a karyoferiny $x genetika $7 D028884
650    _2
$a nádory jater $x genetika $x sekundární $7 D008113
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a ribonukleasa III $x genetika $7 D043244
655    _2
$a časopisecké články $7 D016428
700    1_
$a Svobodova Kovarikova, Alena $u Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic. aluskakovarikova@centrum.cz.
700    1_
$a Grolich, Tomas $u Department of Surgery, University Hospital Brno, Jihlavska 340/20, 62500 Brno, Czech Republic. Grolich.Tomas@fnbrno.cz. Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. Grolich.Tomas@fnbrno.cz.
700    1_
$a Prochazka, Vladimir $u Department of Surgery, University Hospital Brno, Jihlavska 340/20, 62500 Brno, Czech Republic. Prochazka.Vladimir@fnbrno.cz. Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. Prochazka.Vladimir@fnbrno.cz.
700    1_
$a Slaba, Katerina $u Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. kslaba@email.cz.
700    1_
$a Machackova, Tana $u Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic. tana.machackova@gmail.com.
700    1_
$a Halamkova, Jana $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. jana.halamkova@mou.cz.
700    1_
$a Svoboda, Marek $u Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic. msvoboda@mou.cz. Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. msvoboda@mou.cz. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. msvoboda@mou.cz.
700    1_
$a Kala, Zdenek $u Department of Surgery, University Hospital Brno, Jihlavska 340/20, 62500 Brno, Czech Republic. Kala.Zdenek@fnbrno.cz. Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. Kala.Zdenek@fnbrno.cz.
700    1_
$a Kiss, Igor $u Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. kiss@mou.cz. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. kiss@mou.cz.
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic. on.slaby@gmail.com. Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. on.slaby@gmail.com. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. on.slaby@gmail.com. Department of Pathology, University Hospital Brno, Jihlavska 340/20, 62500 Brno, Czech Republic. on.slaby@gmail.com.
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 18 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31510013 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200518132207 $b ABA008
999    __
$a ok $b bmc $g 1524778 $s 1095976
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 18 $e 20190910 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 16-31765A $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a NV16-31765A $p MZ0
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace